BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10817545)

  • 1. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
    Daniel WA; Syrek M; Haduch A
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.
    Wójcikowski J; Maurel P; Daniel WA
    Drug Metab Dispos; 2006 Mar; 34(3):471-6. PubMed ID: 16272405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines.
    Wójcikowski J; Boksa J; Daniel WA
    Biochem Pharmacol; 2010 Oct; 80(8):1252-9. PubMed ID: 20615392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
    Lakshmi VM; Zenser TV; Davis BB
    Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
    Arinç E; Bozcaarmutlu A
    J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application.
    Wójcikowski J; Basińska A; Daniel WA
    Biochem Pharmacol; 2014 Jul; 90(2):188-95. PubMed ID: 24841887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
    Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
    Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes.
    Narimatsu S; Tachibana M; Masubuchi Y; Suzuki T
    Chem Res Toxicol; 1996; 9(1):93-8. PubMed ID: 8924622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
    Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor.
    Machinist JM; Mayer MD; Roberts EM; Surber BW; Rodrigues AD
    Drug Metab Dispos; 1998 Oct; 26(10):970-6. PubMed ID: 9763401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.